Table: Medrx -2021 group results

Medrx

10/02/2022 06:01

Feb 10 (Reuters)- 
          Medrx.Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT     
              Dec 31, 2021    Dec 31, 2020    Dec 31, 2022       YEAR       
                 LATEST         YEAR-AGO         COMPANY         COMPANY    
                 RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales           8 mln          115 mln         289 mln          7 mln     
               (-92.7 pct)     (-32.2 pct)                     (+0.0 pct)   
  Operating     loss 1.06       loss 1.13       loss 1.00     loss 709 mln  
  Recurring     loss 1.07       loss 1.15       loss 1.00     loss 710 mln  
  Net
  Net           loss 1.06       loss 1.11       loss 1.01     loss 711 mln  
  EPS        loss 49.62 yen  loss 68.61 yen  loss 40.91 yen  loss 28.94 yen 
  Ann Div          NIL             NIL             NIL                      
  -Q2 Div          NIL             NIL             NIL                      
  -Q4 Div          NIL             NIL             NIL                      
  
  NOTE - Medrx.Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T